Single-sex vaccination is most effective at reducing HPV infection

In this week's PLoS Medicine, Johannes Bogaards of VU University, the Netherlands and colleagues use mathematical models to investigate whether vaccinating females only, males only, or both sexes is the best way to achieve the most effective reduction in the population prevalence of sexually-transmitted infections.

Specifically for (HPV), the authors found that single-sex vaccination was the most effective strategy for prevention of disease and that it was preferable to vaccinate the sex with the highest prevaccine prevalence of HPV infection which for HPV is females.

The authors say: "Our results provide a justification, under most circumstances, for the intuitively plausible strategy of targeting intervention at the subgroups that harbor most infections and that act as a reservoir for transmission…We show that, once routine vaccination of one sex is in place, increasing the coverage in that sex is much more effective in bolstering herd immunity than switching to a policy that includes both sexes."

More information: Bogaards JA, Kretzschmar M, Xiridou M, Meijer CJLM, Berkhof J, et al. (2011) Sex-Specific Immunization for Sexually Transmitted Infections Such as Human Papillomavirus: Insights from Mathematical Models. PLoS Med 8(12): e1001147. doi:10.1371/journal.pmed.1001147

add to favorites email to friend print save as pdf

Related Stories

HPV vaccination more likely if mothers approve

Apr 12, 2010

College women were more likely to be vaccinated against human papillomavirus (HPV) if their mothers communicated with them about sex and if they thought their mothers would approve of their getting vaccinated, according to ...

Recommended for you

FOLFOXIRI plus bevacizumab ups outcome in metastatic CRC

12 hours ago

(HealthDay)—For patients with untreated metastatic colorectal cancer, chemotherapy with fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) plus bevacizumab improves outcome versus fluorouracil, ...

Cancer exosome 'micro factories' aid in cancer progression

16 hours ago

Exosomes, tiny, virus-sized particles released by cancer cells, can bioengineer micro-RNA (miRNA) molecules resulting in tumor growth. They do so with the help of proteins, such as one named Dicer. New research from The University ...

User comments